Latest News
Cipher Pharmaceuticals Reports Third Quarter 2024 Results
(All figures are presented in U.S. Dollars)
Cipher Pharmaceuticals Reports Third Quarter 2024 Results
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the three and...
Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the...
Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call
MISSISSAUGA, ON , Nov. 4, 2024 /CNW/ -ย Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for the third quarter of 2024 after the market close on Thursday, November 7, 2024 . The Company will also hold a conference call on Friday, November 8, 2024 at 8:30am ET to discuss the results and corporate developments.
Cipher Pharmaceuticals Inc is among the group of overvalued stocks on the Toronto Stock Exchange. This means the consensus value for each stock on this list is below its current price. This report is generated monthly. It provides the close price and target price for these companies along with the...
Stocks in play: Cipher Pharmaceuticals Inc.
Announced today the appointment of Hamed Ghanei as Chief Business Officer. Dr. Ghanei has over 15 years ...
Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today the appointment of Hamed Ghanei as Chief Business...
Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer
MISSISSAUGA, ON , Oct. 8, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") announced today the appointment of Hamed Ghanei as Chief Business Officer ("CBO").
Cipher Pharmaceuticals Inc is among the group of overvalued stocks on the Toronto Stock Exchange. This means the consensus value for each stock on this list is below its current price. This report is generated monthly. It provides the close price and target price for these companies along with the...
Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today that its partner, Moberg Pharma AB ("Moberg"), issued...
Cipher Pharmaceuticals Inc is among the group of top performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year. This report is generated monthly. It...
Cipher Pharmaceuticals Reports Second Quarter 2024 Results
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the three and...
Cipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the...
Stocks in play: Cipher Pharmaceuticals Inc.
Announces the signing of a definitive asset purchase agreement with ParaPRO LLC and the closing of the ...
Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announces the signing of a definitive asset purchase agreement with...